Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.
Chris Lange
Arrowhead Pharmaceuticals shares made a considerable gain early on Thursday after the firm announced data from its hepatitis B clinical trial with ARO-HBV.
Chris Lange
Arrowhead Pharmaceuticals shares made a solid gain on Tuesday after the company gave an update on its midstage study of ARO-HBV in the treatment of patients with chronic hepatitis B virus infection.
Chris Lange
Arrowhead Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm presented new data from its midstage study for the treatment of hepatitis B infection.
Chris Lange
Now that stocks have surged to all-time highs yet again in 2019, and with the start of 2020 rapidly approaching, investors need to look back over what has been working and what has not. The Dow was...
Jon C. Ogg
Now that stocks have surged to all-time highs yet again in 2019, and with the start of 2020 rapidly approaching, investors need to look back over what has been working and what has not. The Dow was...
Jon C. Ogg
The top analyst upgrades, downgrades and initiations on Friday included Aerojet Rocketdyne, Apple, Baidu, Biogen, Chesapeake Energy, Chipotle Mexican Grill, McDonald's, Nike, Procter & Gamble and...
Jon C. Ogg
December 20, 2016: Here are four stocks trading with relatively heavy volume among 51 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 2 to 1...
Paul Ausick
December 12, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by nearly 2 to 1...
Paul Ausick
November 30, 2016: Here are four stocks trading with relatively heavy volume among 62 equities making new 52-week lows in Wednesday’s session. On the NYSE, decliners led advancers by about 3 to...
Paul Ausick
Arrowhead Pharmaceuticals shares plummeted early on Wednesday after the company gave an update on its hepatitis B virus treatment.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Tuesday include Albermarle, BB&T, Cheniere Energy Partners, Chesapeake Energy, Kinder Morgan, Red Hat and Roku.
Jon C. Ogg
As the second week of the New Year is now underway, a few biotech companies made sizable runs to kick off the week.
Chris Lange
The U.S. presidential election is now over and markets have seemingly recovered to just below their highs but there are still some laggards.
Chris Lange
Safe stocks to buy come with analyst upside targets of 15% or less at this point in the bull market. The projected upside in speculative companies is often much, much more.
Paul Ausick